Literature DB >> 23002068

Regression models for censored serological data.

George Kafatos1,2, Nick Andrews2, Kevin J McConway1, Paddy Farrington1.   

Abstract

The impact was assessed of censored serological measurements on regression equations fitted to data from panels of sera tested by different laboratories, for the purpose of standardizing serosurvey results to common units. Several methods that adjust for censoring were compared, such as deletion, simple substitution, multiple imputation and censored regression. Simulations were generated from different scenarios for varying proportions of data censored. The scenarios were based on serological panel comparisons tested by different national laboratories and assays as part of the European Sero-Epidemiology Network 2 project. The results showed that the simple substitution and deletion methods worked reasonably well for low proportions of data censored (<20 %). However, in general, the censored regression method gave estimates closer to the truth than the other methods examined under different scenarios, such as types of equations used and violation of regression assumptions. Interval-censored regression produced the least biased estimates for assay data resulting from dilution series. Censored regression produced the least biased estimates in comparison with the other methods examined. Moreover, the results suggest using interval-censored regression methods for assay data resulting from dilution series.

Mesh:

Year:  2012        PMID: 23002068     DOI: 10.1099/jmm.0.050062-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  4 in total

1.  Lasso regularization for left-censored Gaussian outcome and high-dimensional predictors.

Authors:  Perrine Soret; Marta Avalos; Linda Wittkop; Daniel Commenges; Rodolphe Thiébaut
Journal:  BMC Med Res Methodol       Date:  2018-12-04       Impact factor: 4.615

2.  Estimating seroprevalence of vaccine-preventable infections: is it worth standardizing the serological outcomes to adjust for different assays and laboratories?

Authors:  G Kafatos; N Andrews; K J McConway; C Anastassopoulou; C Barbara; F De Ory; K Johansen; J Mossong; K Prosenc; R Vranckx; A Nardone; R Pebody; P Farrington
Journal:  Epidemiol Infect       Date:  2014-11-25       Impact factor: 4.434

3.  The Statistical Value of Raw Fluorescence Signal in Luminex xMAP Based Multiplex Immunoassays.

Authors:  Edmond J Breen; Woei Tan; Alamgir Khan
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

4.  Evaluation of a polyvalent foot-and-mouth disease virus vaccine containing A Saudi-95 against field challenge on large-scale dairy farms in Saudi Arabia with the emerging A/ASIA/G-VII viral lineage.

Authors:  Nicholas A Lyons; Anna B Ludi; Ginette Wilsden; Pip Hamblin; Ibrahim Ahmed Qasim; Simon Gubbins; Donald P King
Journal:  Vaccine       Date:  2017-11-03       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.